Research on curcumin: A meta-analysis of potentially malignant disorders

Journal of Cancer Research and Therapeutics

Volumn 12, Issue 1, 2016, Pages 175-181

  Ara, Syeda Arshiya ^a   Mudda, Jayashree ^b   Lingappa, Ashok ^c   Rao, Purushottam ^d  

^a PDA COLLEGE OF ENGINEERING   (India)

^b HKES SN Institute of Dental Sciences and Research Center   (India)

^c Davangere   (India)

^d HKES's College of pharmacy   (India)

Author keywords

Curcumin; leukoplakia; lichen planus; oral submucous fibrosis; potentially malignant disorders

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CURCUMIN; MALONALDEHYDE; ANGIOGENESIS INHIBITOR; CYTOKINE;

ARTICLE; BURNING SENSATION; CANCER STAGING; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; LEUKOPLAKIA; LICHEN PLANUS; MALIGNANT TRANSFORMATION; META ANALYSIS; MOUTH DISEASE; NONHUMAN; PRECANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); VISUAL ANALOG SCALE; CHEMISTRY; CURCUMA; METABOLISM; NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PATHOLOGY;

ANGIOGENESIS INHIBITORS; CURCUMA; CURCUMIN; CYTOKINES; HUMANS; NEOPLASMS; ORAL SUBMUCOUS FIBROSIS;

EID: 84966601440     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.171370     Document Type: Article

References (8)

1. Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets 2011;12:332-47.
2. Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 2010;52:251-6.
3. Das AD, Balan A, Sreelatha KT. Comparative study of the efficacy of curcumin and turmeric oil as chemopreventive agents in oral submucous fibrosis: A clinical and histopathological evaluation. J Indian Acad Oral Med Radiol 2010;22:88-92.
4. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-900.
5. Rao KP, Vijaybhaskar D, Pratima S. Formulation of topical oral gel for the treatment of oral sub mucous fibrosis. Sch Res Libr Pharm Lett 2011;3:103-12.
6. Deng YT, Chen HM, Cheng SJ, Chiang CP, Kuo MY. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin. Oral Oncol 2009;45:e99-105.
7. Zhang SS, Gong ZJ, Li WH, Wang X, Ling TY. Antifibrotic effect of curcumin in TGF-ß 1-induced myofibroblasts from human oral mucosa. Asian Pac J Cancer Prev 2012;13:289-94.
8. Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011;17 Suppl 1:42-57.